Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients Multicountry, Multicenter, Observational, Prospective, Primary Data, Real-world Settings

NCT05603845 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05603845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05603845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients Multicountry, Multicenter, Observational, Prospective, Primary Data, Real-world Settings
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 20, 2023
Completion date
April 10, 2025
Enrollment
291 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma